Boca Juniors starlet Rodrigo Bentancur undergoes Juventus medical ahead of 2017-18 season
Real Madrid and Manchester United had been linked with his services in the past.
Hotly tipped Boca Juniors youngster Rodrigo Bentancur has undergone a medical at Juventus ahead of completing a move to the Serie A giants. Real Madrid, Manchester United, Arsenal and AC Milan had all been linked with the "Uruguayan Pogba" in the past, but The Old Lady won the race after agreeing to activate a €9.4m (£8m, $10m) clause to secure his services.
The 19-year-old midfielder is considered the next big thing to emerge from Boca, having registered 46 appearances for the Xeneizes since making his first-team debut in April 2015.
Last year ESPN reported Arsenal were closely monitoring his situation ahead of luring him to the Emirates Stadium, while Marca also linked the Uruguay U20 international with a move to Real Madrid.
In October 2016 Boca president Daniel Angelici confirmed Real Madrid, Manchester United and Milan had all made approaches. However, he added that Juventus were expected to beat them as the Italian giants had a first option to secure his services as part of the deal that saw Carlos Tevez returning to the Argentine side in the summer of 2015.
"It is already signed. When I was in Switzerland recently Juventus informed me that that they were going to activate the option so I will travel to Turin soon in order to complete the deal. I think it's very good business for Boca," Angelici told Argentinian TV TyC Sports.
"He must have something because there were a lot of clubs interested. Real Madrid made a proposal, Manchester United also came and Milan made a €14m formal offer to sign him," he added.
Juventus have now confirmed the long-expected move as the purchase option – set at €9.4m – needed to be activated before 20 April 2017.
"Rodrigo Bentancur arrived at J-Medical this afternoon. The Uruguayan midfielder is carrying out routine tests ahead of a proposed move to Juventus from Boca Juniors," Juventus confirmed on the club's official website.
© Copyright IBTimes 2024. All rights reserved.